Performance of 68 Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence

Volume: 18, Issue: 11, Pages: 84 - 84
Published: Sep 9, 2017
Abstract
Recently introduced Gallium-68 labeled PSMA-ligands such as HBED-CC (68Ga-PSMA) have shown promise for unmet diagnostic needs in prostate cancer. null null null null null null null null null null null null null null null null null null null null null null null null null null null 68Ga-PSMA has demonstrated improved detection rates and specificity for prostate cancer compared to standard imaging approaches. In the setting of primary disease,...
Paper Details
Title
Performance of 68 Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence
Published Date
Sep 9, 2017
Volume
18
Issue
11
Pages
84 - 84
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.